Delivery Order SPE2DB22D1017-SPE2DB25FE7DE
Award Date
10/11/24
Potential Completion Date
10/15/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.72 delivery order contract is for the supply of the medication Qulipta 60 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 21, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,237.40, is for the delivery of the medication Qulipta 60 mg tablets. This is a firm fixed-price delivery order contract, with an ultimate completion date of January 14, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Qulipta 60 mg tablets. The $1,154.79 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical and medical supplies to support military...
This federal contract award, valued at $3,079.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the medication Qulipta 60 mg Tablet 30s, with a performance period ending on May 21, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of the pharmaceutical product Qulipta 10 mg tablet in 30-count packages. The $1,222.23 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRWGD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the drug Qulipta 60 mg tablets. The fixed-price delivery order has a ceiling value of $3,849.30 and a completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.14, is for the supply of Qulipta 30 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order, with a performance period through February 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $3,135.65. The contract is for the supply of Qulipta 60 mg tablets. The contract is not set aside and is a firm fixed price delivery order, with a performance period ending on June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,353.23 delivery order contract is for the supply of Qulipta 30 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of August 21, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.79 firm fixed-price delivery order is for the supply of 4568175621 - Qulipta 60 mg tablets. The contract has a performance period through May 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...